Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study
- 30 April 2008
- journal article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 9 (4), 359-366
- https://doi.org/10.1016/s1470-2045(08)70038-x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Food, nutrient and heterocyclic amine intake and the risk of bladder cancerEuropean Journal of Cancer, 2007
- LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite InstabilityPLOS ONE, 2007
- Polymorphisms in one‐carbon metabolism and trans‐sulfuration pathway genes and susceptibility to bladder cancerInternational Journal of Cancer, 2007
- Large-Scale Evaluation of Candidate Genes Identifies Associations between VEGF Polymorphisms and Bladder Cancer RiskPLoS Genetics, 2007
- Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke, and GenderCancer Epidemiology, Biomarkers & Prevention, 2006
- 5,10-Methylenetetrahydrofolate Reductase Polymorphisms and Pharmacogenetics: A New Role of Single Nucleotide Polymorphisms in the Folate Metabolic Pathway in Human Health and DiseaseNutrition Reviews, 2005
- Constitutional short telomeres are strong genetic susceptibility markers for bladder cancerCarcinogenesis: Integrative Cancer Research, 2005
- Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesisOncogene, 2004
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002
- Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort studyCancer Genetics and Cytogenetics, 1995